Answers are grounded in this paper and cite their sources.
Our results revealed that the pharmacokinetics of osimertinib were significantly changed by voriconazole and fluconazole in rats, whereas it was slightly affected by itraconazole. This work will contribute to a more comprehensive understanding of the pharmacokinetic properties of osimertinib when co-administered with triazole antifungals.
No takes yet. Share an insight, caveat, or question.
Lou et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: